Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 1, 2023
0Patent Application Number
171724900
Date Filed
February 10, 2021
0Patent Citations
Patent Citations Received
Patent Primary Examiner
Provided is a stable pharmaceutical composition, comprising an anti-human TSLP receptor antibody, capable of inhibiting the generation of chemically modified substances, such as deamidated forms and oxidized forms, or degradants or multimers. The pharmaceutical composition comprises an anti-human TSLP receptor antibody, a pharmaceutically acceptable buffer, arginine or a pharmaceutically acceptable salt thereof, and a surfactant.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
